"EFFECT OF HIGH VERSUS LOW DOSES OF HUMAN RECOMBINANT ERYTHROPOIETIN ON THE ANEMIA OF PREMATURITY"

Recombinant human erythropoietin (rh-EPO) is known to accelerate erythropoiesis in preterm infants. The purpose of this study was to compare the effectiveness of early treatment with two doses of rh-EPO (high vs. low dose) in the management of anemia of prematurity. Twenty preterm infants with hemat...

Full description

Bibliographic Details
Main Authors: A. Mohammadzadeh, F. Naseri
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2005-04-01
Series:Acta Medica Iranica
Subjects:
Online Access:https://acta.tums.ac.ir/index.php/acta/article/view/2971